These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27009451)

  • 1. Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.
    Strom T; Wishka C; Caudell JJ
    Cancer Control; 2016 Jan; 23(1):6-11. PubMed ID: 27009451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.
    Vargo JA; Ferris RL; Ohr J; Clump DA; Davis KS; Duvvuri U; Kim S; Johnson JT; Bauman JE; Gibson MK; Branstetter BF; Heron DE
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):480-8. PubMed ID: 25680594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
    Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
    Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
    Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer.
    Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Gagnon GJ; Hwang J; Slack RS; Noone AM; Harter KW
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1411-9. PubMed ID: 20056341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.
    Román A A; Jodar C; Perez-Rozos A; Lupiañez-Perez Y; Medina JA; Gomez-Millan J
    Crit Rev Oncol Hematol; 2018 Feb; 122():194-201. PubMed ID: 29373181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study.
    Heron DE; Rwigema JC; Gibson MK; Burton SA; Quinn AE; Ferris RL
    Am J Clin Oncol; 2011 Apr; 34(2):165-72. PubMed ID: 20686406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors.
    Lim CM; Clump DA; Heron DE; Ferris RL
    Oral Oncol; 2013 May; 49(5):401-6. PubMed ID: 23332685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
    Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A
    Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.
    Rwigema JC; Heron DE; Ferris RL; Gibson M; Quinn A; Yang Y; Ozhasoglu C; Burton S
    Am J Clin Oncol; 2010 Jun; 33(3):286-93. PubMed ID: 19875950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
    Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
    Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: implications of treatment duration and tumor volume.
    Vargo JA; Heron DE; Ferris RL; Rwigema JC; Kalash R; Wegner RE; Ohr J; Burton S
    Head Neck; 2014 Sep; 36(9):1349-55. PubMed ID: 24038398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck.
    Echevarria MI; Yang GQ; Chen DT; Kirtane K; Russell J; Kish J; Muzaffar J; Otto K; Padhya T; McMullen C; Patel K; Chung CH; Caudell JJ
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):341-347. PubMed ID: 37105404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reirradiation for head and neck squamous cell carcinoma: Indications and results].
    Biau J; Moreau J; Blanchard P; Thariat J; Miroir J; Lapeyre M
    Cancer Radiother; 2019 Oct; 23(6-7):559-564. PubMed ID: 31451359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancer.
    Vargo JA; Heron DE; Ferris RL; Rwigema JC; Wegner RE; Kalash R; Ohr J; Kubicek GJ; Burton S
    Radiother Oncol; 2012 Jul; 104(1):91-5. PubMed ID: 22677037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reirradiation of head and neck cancer using modern highly conformal techniques.
    Ho JC; Phan J
    Head Neck; 2018 Sep; 40(9):2078-2093. PubMed ID: 29684256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.